Future of endometriosis research

Peter Simsa, Attila Mihalyi, Cleophas M. Kyama, Jason M. Mwenda, V. Fülöp, Thomas M. D'Hooghe

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In women of reproductive age, health economic costs are estimated to be considerably higher for endometriosis than for conditions such as Crohn's disease, migraine and hypertension, and similar to the cost of diabetes. However, more awareness of endometriosis among patients and politicians is needed to create a better climate for research funding in the area of endometriosis in particular, and women's health in general. Recent collaboration between patients, physicians and politicians in the EU has shown that such efforts can be successful. Many arguments exist to organize the clinical care for women with advanced endometriosis in centers of excellence, but continuing education of primary-care physicians also remains a priority. New molecular techniques are resulting in new hormonal and nonhormonal targets for the noninvasive diagnosis and treatment of endometriosis. A future diagnostic serum assay might contain various elements from inflammatory serum markers to genetic/microarray/proteomics markers, owing to the multifactorial features of endometriosis.

Original languageEnglish
Pages (from-to)647-654
Number of pages8
JournalWomen's Health
Volume3
Issue number5
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Endometriosis
Research
Continuing Education
Reproductive Health
Primary Care Physicians
Women's Health
Migraine Disorders
Climate
Crohn Disease
Health Care Costs
Proteomics
Biomarkers
Economics
Hypertension
Physicians
Costs and Cost Analysis
Serum

Keywords

  • Center of excellence
  • Dioxin
  • Endometriosis
  • Noninvasive diagnosis
  • Proteomics
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Simsa, P., Mihalyi, A., Kyama, C. M., Mwenda, J. M., Fülöp, V., & D'Hooghe, T. M. (2007). Future of endometriosis research. Women's Health, 3(5), 647-654. https://doi.org/10.2217/17455057.3.5.647

Future of endometriosis research. / Simsa, Peter; Mihalyi, Attila; Kyama, Cleophas M.; Mwenda, Jason M.; Fülöp, V.; D'Hooghe, Thomas M.

In: Women's Health, Vol. 3, No. 5, 09.2007, p. 647-654.

Research output: Contribution to journalArticle

Simsa, P, Mihalyi, A, Kyama, CM, Mwenda, JM, Fülöp, V & D'Hooghe, TM 2007, 'Future of endometriosis research', Women's Health, vol. 3, no. 5, pp. 647-654. https://doi.org/10.2217/17455057.3.5.647
Simsa P, Mihalyi A, Kyama CM, Mwenda JM, Fülöp V, D'Hooghe TM. Future of endometriosis research. Women's Health. 2007 Sep;3(5):647-654. https://doi.org/10.2217/17455057.3.5.647
Simsa, Peter ; Mihalyi, Attila ; Kyama, Cleophas M. ; Mwenda, Jason M. ; Fülöp, V. ; D'Hooghe, Thomas M. / Future of endometriosis research. In: Women's Health. 2007 ; Vol. 3, No. 5. pp. 647-654.
@article{ae5e5ca22b774c2b845e939cc70adc44,
title = "Future of endometriosis research",
abstract = "In women of reproductive age, health economic costs are estimated to be considerably higher for endometriosis than for conditions such as Crohn's disease, migraine and hypertension, and similar to the cost of diabetes. However, more awareness of endometriosis among patients and politicians is needed to create a better climate for research funding in the area of endometriosis in particular, and women's health in general. Recent collaboration between patients, physicians and politicians in the EU has shown that such efforts can be successful. Many arguments exist to organize the clinical care for women with advanced endometriosis in centers of excellence, but continuing education of primary-care physicians also remains a priority. New molecular techniques are resulting in new hormonal and nonhormonal targets for the noninvasive diagnosis and treatment of endometriosis. A future diagnostic serum assay might contain various elements from inflammatory serum markers to genetic/microarray/proteomics markers, owing to the multifactorial features of endometriosis.",
keywords = "Center of excellence, Dioxin, Endometriosis, Noninvasive diagnosis, Proteomics, Treatment",
author = "Peter Simsa and Attila Mihalyi and Kyama, {Cleophas M.} and Mwenda, {Jason M.} and V. F{\"u}l{\"o}p and D'Hooghe, {Thomas M.}",
year = "2007",
month = "9",
doi = "10.2217/17455057.3.5.647",
language = "English",
volume = "3",
pages = "647--654",
journal = "Women's health (London, England)",
issn = "1745-5065",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Future of endometriosis research

AU - Simsa, Peter

AU - Mihalyi, Attila

AU - Kyama, Cleophas M.

AU - Mwenda, Jason M.

AU - Fülöp, V.

AU - D'Hooghe, Thomas M.

PY - 2007/9

Y1 - 2007/9

N2 - In women of reproductive age, health economic costs are estimated to be considerably higher for endometriosis than for conditions such as Crohn's disease, migraine and hypertension, and similar to the cost of diabetes. However, more awareness of endometriosis among patients and politicians is needed to create a better climate for research funding in the area of endometriosis in particular, and women's health in general. Recent collaboration between patients, physicians and politicians in the EU has shown that such efforts can be successful. Many arguments exist to organize the clinical care for women with advanced endometriosis in centers of excellence, but continuing education of primary-care physicians also remains a priority. New molecular techniques are resulting in new hormonal and nonhormonal targets for the noninvasive diagnosis and treatment of endometriosis. A future diagnostic serum assay might contain various elements from inflammatory serum markers to genetic/microarray/proteomics markers, owing to the multifactorial features of endometriosis.

AB - In women of reproductive age, health economic costs are estimated to be considerably higher for endometriosis than for conditions such as Crohn's disease, migraine and hypertension, and similar to the cost of diabetes. However, more awareness of endometriosis among patients and politicians is needed to create a better climate for research funding in the area of endometriosis in particular, and women's health in general. Recent collaboration between patients, physicians and politicians in the EU has shown that such efforts can be successful. Many arguments exist to organize the clinical care for women with advanced endometriosis in centers of excellence, but continuing education of primary-care physicians also remains a priority. New molecular techniques are resulting in new hormonal and nonhormonal targets for the noninvasive diagnosis and treatment of endometriosis. A future diagnostic serum assay might contain various elements from inflammatory serum markers to genetic/microarray/proteomics markers, owing to the multifactorial features of endometriosis.

KW - Center of excellence

KW - Dioxin

KW - Endometriosis

KW - Noninvasive diagnosis

KW - Proteomics

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=35848962108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848962108&partnerID=8YFLogxK

U2 - 10.2217/17455057.3.5.647

DO - 10.2217/17455057.3.5.647

M3 - Article

C2 - 19804042

AN - SCOPUS:35848962108

VL - 3

SP - 647

EP - 654

JO - Women's health (London, England)

JF - Women's health (London, England)

SN - 1745-5065

IS - 5

ER -